GO:0120550 methyltransferase cap2 activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0120550 methyltransferase cap2 activity catalyzes the 2'-O-ribose methylation of the second transcribed nucleotide of mRNA and snRNA, using S-adenosyl-L-methionine as the methyl donor.
• This cap2 methylation is performed by a conserved enzyme complex in which CMTR1 adds the first ribose methyl (cap1) and CMTR2 adds the second (cap2).
• Loss of cap2 ribose methylation causes embryonic lethality and fertility defects in mammals, demonstrating an essential developmental role.
• The modification is part of the mRNA cap-proximal methylation pathway that influences RNA stability, translation, and innate immune recognition.
• CMTR2 is the principal human cap2 methyltransferase, and its activity depends on the cap1 structure generated by CMTR1.
• CRISPR knockout, point-mutation, and knock-in models are key tools for dissecting the function of cap2 methyltransferase genes in development and disease.
Description
GO:0120550 methyltransferase cap2 activity is a molecular function that adds a methyl group to the 2'-O position of the ribose of the second transcribed nucleotide in mRNA and snRNA. This reaction occurs on RNAs that already carry an N7-methylguanosine cap and a 2'-O-methyl group on the first transcribed nucleotide (cap1), converting them to cap2 structures. The activity uses S-adenosyl-L-methionine (SAM) as the methyl donor and produces S-adenosyl-L-homocysteine (SAH) as a byproduct. Cap2 methylation is part of a conserved cap-proximal ribose methylation pathway that decorates the 5' end of transcripts and influences how RNAs are recognized by the cellular machinery. In mammals, the enzyme responsible for cap2 methylation is CMTR2, which acts after CMTR1 has installed the cap1 modification. Studies in knockout mice have shown that loss of cap2 methylation leads to embryonic lethality and impaired fertility, indicating that this modification is essential for normal development. For researchers, GO:0120550 provides a precise functional annotation to study RNA modification enzymes, cap biology, and the interplay between RNA methylation and gene expression. Understanding this activity helps explain how cells fine-tune mRNA and snRNA function and how defects in cap methylation may contribute to disease.
methyltransferase cap2 activity At A Glance
| GO ID | GO:0120550 |
|---|---|
| GO term | methyltransferase cap2 activity |
| Ontology | molecular_function |
| Synonym | cap2-MTase activity; mRNA (nucleoside-2'-O-)-methyltransferase activity |
| Major function | Catalyzes 2'-O-ribose methylation of the second transcribed nucleotide in mRNA and snRNA caps |
| Substrate | 5'-end (N7-methyl 5'-triphosphoguanosine)-(2'-O-methyl-ribonucleoside)-(ribonucleotide) in mRNA or snRNA |
| Cofactor | S-adenosyl-L-methionine (SAM) as methyl donor |
| Product | Cap2 structure with 2'-O-methyl on the second nucleotide, plus S-adenosyl-L-homocysteine and H+ |
| Representative enzyme | CMTR2 in humans |
What Is GO:0120550?
In simple terms, GO:0120550 methyltransferase cap2 activity is the enzyme activity that puts a small chemical tag (a methyl group) on the sugar of the second nucleotide at the very start of an mRNA or snRNA molecule. More formally, it catalyzes the reaction in which a 5'-end (N7-methyl 5'-triphosphoguanosine)-(2'-O-methyl-ribonucleoside)-(ribonucleotide) in mRNA or snRNA reacts with S-adenosyl-L-methionine to produce a 5'-end (N7-methyl 5'-triphosphoguanosine)-(2'-O-methyl-ribonucleoside)-(2'-O-methyl-ribonucleotide) in mRNA or snRNA, along with S-adenosyl-L-homocysteine and H+. This activity specifically methylates the ribose of the second transcribed nucleotide, distinguishing it from cap1 methylation, which modifies the first transcribed nucleotide.
Why Is methyltransferase cap2 activity Important in Cell Biology?
GO:0120550 methyltransferase cap2 activity is important because it generates a conserved chemical mark on the 5' end of mRNA and snRNA that affects RNA fate and organismal development. Genetic studies in mice have shown that eliminating cap2 methylation causes embryonic lethality and fertility defects, highlighting its non-redundant role in mammals. Because cap-proximal modifications influence how RNAs are translated and recognized by the immune system, understanding this activity has implications for RNA biology, developmental genetics, and therapeutic RNA design.
• Essential for mammalian embryonic development, as loss of cap2 methylation causes embryonic lethality in mice.
• Required for normal fertility, with defects observed in knockout models lacking cap2 methylation.
• Part of the conserved mRNA cap-proximal ribose methylation pathway that modifies the 5' end of transcripts.
• Influences RNA stability and translation by altering the cap structure recognized by cellular machinery.
• Contributes to the distinction between self and non-self RNA, relevant for innate immune sensing.
• Provides a functional annotation for studying CMTR2 and related cap methyltransferases.
• Relevant to snRNA biology, as the activity also targets snRNAs.
• Offers a target for CRISPR-based functional genomics of RNA modification enzymes.
• Helps interpret disease-associated variants in cap methylation genes.
• Guides the design of modified therapeutic RNAs with optimized cap structures.
Molecular Mechanism of methyltransferase cap2 activity
Substrate recognition and cap1 prerequisite
In simple terms: The enzyme only works on RNAs that already have a first methyl group on the cap.
Cap2 methyltransferase activity acts on mRNAs and snRNAs that already carry an N7-methylguanosine cap and a 2'-O-methyl group on the first transcribed nucleotide, the cap1 structure. This substrate specificity ensures that cap2 methylation occurs after cap1 formation, creating an ordered pathway of cap-proximal ribose methylation. In humans, CMTR1 generates the cap1 structure that is required for subsequent cap2 methylation by CMTR2.
Catalytic transfer of the methyl group
In simple terms: The enzyme takes a methyl group from SAM and attaches it to the sugar of the second nucleotide.
The catalytic step of GO:0120550 transfers a methyl group from S-adenosyl-L-methionine to the 2'-O position of the ribose of the second transcribed nucleotide. This reaction converts the cap1 structure into a cap2 structure and releases S-adenosyl-L-homocysteine and H+. The activity is classified as a methyltransferase and is specific for the second nucleotide, distinguishing it from cap1 methyltransferases that modify the first nucleotide.
Enzyme complex and domain organization
In simple terms: The enzyme has a conserved catalytic domain that carries out the methylation.
Human CMTR2 is the principal enzyme responsible for cap2 methyltransferase activity and belongs to a conserved family of 2'-O-ribose methyltransferases. The catalytic domain of these enzymes adopts a Rossmann-like fold typical of SAM-dependent methyltransferases, and the family has been described as horizontally mobile in evolution. The activity requires the cap1 structure as a substrate, linking CMTR2 function to upstream CMTR1 activity.
Regulation and developmental requirement
In simple terms: Cells need this modification for normal development and fertility.
Genetic ablation of cap2 methylation in mice leads to embryonic lethality and fertility defects, indicating that the activity is developmentally regulated and essential. The requirement for CMTR2 in mammalian embryonic development has been demonstrated through knockout studies, which show that loss of cap2 methylation is not tolerated. These findings suggest that the activity is tightly controlled and integrated with broader RNA processing pathways.
Key Genes Involved in GO:0120550 methyltransferase cap2 activity
The following genes and proteins are directly implicated in GO:0120550 methyltransferase cap2 activity or its regulatory context, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CMTR2 | Principal human cap2 methyltransferase that catalyzes 2'-O-ribose methylation of the second transcribed nucleotide | Core enzyme for studying GO:0120550; knockout causes developmental defects |
| CMTR1 | Generates the cap1 structure required as substrate for cap2 methylation | Upstream enzyme in the cap-proximal methylation pathway |
| RNMT | Responsible for N7-methylguanosine cap formation, a prerequisite for cap1 and cap2 | Provides the initial cap structure needed for downstream methylation |
| RNGTT | Catalyzes the initial guanosine cap addition to mRNA | Early step in cap formation relevant to cap2 substrate availability |
| POLR2A | Transcribes mRNA and snRNA that receive cap2 methylation | Defines the RNA substrates for cap2 activity |
| NUDT16 | Decapping enzyme that can act on methylated caps | Potential regulator of cap2-modified RNA turnover |
| DCP1A | Component of the decapping complex that removes caps from mRNA | Affects stability of cap2-methylated transcripts |
| DCP2 | Catalytic subunit of the decapping complex | Influences turnover of cap2-modified mRNAs |
| XRN1 | 5'-3' exoribonuclease that degrades decapped RNA | Downstream of cap removal on cap2-methylated transcripts |
| EIF4E | Cap-binding protein that recognizes the 5' cap during translation initiation | Cap2 methylation may influence translation initiation |
| EIF4G | Scaffold protein in translation initiation complex | Links cap recognition to translation |
| METTL3 | m6A methyltransferase that modifies internal adenosines | Comparison point for RNA methylation pathways |
| METTL14 | Partner of METTL3 in m6A methylation | Context for RNA methyltransferase research |
| WTAP | Regulatory subunit of the m6A methyltransferase complex | Illustrates modular RNA methyltransferase complexes |
| FTO | m6A demethylase | Shows reversibility of RNA methylation |
| ALKBH5 | m6A demethylase | Another example of RNA methylation dynamics |
| Pax6 | Transcription factor that associates with H3K4 methyltransferases | Example of methyltransferase crosstalk in gene regulation |
How Is methyltransferase cap2 activity Regulated?
The activity of GO:0120550 is regulated at multiple levels. Substrate availability is controlled by upstream cap-forming enzymes, particularly CMTR1, which generates the cap1 structure required for cap2 methylation. Developmental studies show that the activity is essential, as knockout of CMTR2 causes embryonic lethality and fertility defects, suggesting tight developmental regulation. The broader cap-proximal methylation pathway is conserved and horizontally mobile in evolution, indicating that its regulation is integrated with RNA processing and developmental programs.
methyltransferase cap2 activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CMTR2 | Embryonic lethality and fertility defects in knockout mice | CMTR2 knockout mouse and cell lines |
| CMTR1 | Cap1 methylation defects affecting development | CMTR1 knockout cells to block cap2 substrate |
| RNMT | Impaired cap formation and RNA stability | RNMT conditional knockout models |
| EIF4E | Translation initiation defects | EIF4E point-mutation models |
| METTL3 | RNA methylation-related cancer biology | METTL3 knockout and overexpression models |
Developmental disorders and embryonic lethality
Loss of cap2 methyltransferase activity in mice leads to embryonic lethality, demonstrating that this modification is required for normal development. CMTR2 knockout embryos fail to develop properly, and fertility is impaired in surviving models, linking cap2 methylation to reproductive biology. These findings suggest that mutations affecting GO:0120550 could contribute to developmental disorders in humans.
RNA modification and innate immunity
Cap-proximal ribose methylation influences how RNAs are recognized by the innate immune system, as methylated caps help distinguish self from non-self RNA. Defects in cap2 methylation could therefore alter immune sensing of endogenous transcripts. This connection makes GO:0120550 relevant to autoimmune and inflammatory conditions linked to RNA misrecognition.
Cancer and RNA metabolism
Altered RNA methylation pathways, including cap-proximal modifications, can affect gene expression programs relevant to cancer. While direct evidence for CMTR2 in cancer is limited in the provided literature, the broader role of RNA methyltransferases in tumor biology supports further investigation. Studying GO:0120550 may reveal vulnerabilities in cancers dependent on cap methylation.
From methyltransferase cap2 activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is CMTR2 required for embryonic development? | CMTR2 knockout mouse |
| Does cap2 methylation affect fertility? | CMTR2 knockout and conditional models |
| What is the substrate specificity of cap2 methyltransferase? | Point mutations in CMTR2 catalytic domain |
| How does cap2 methylation affect RNA stability? | Knock-in of tagged CMTR2 followed by RNA-seq |
| Can cap2 methylation be visualized in cells? | Knock-in of fluorescently tagged CMTR2 |
| Does overexpression of CMTR2 alter transcript fate? | CMTR2 overexpression cell lines |
How to Study the methyltransferase cap2 activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript abundance and processing | Compare wild-type and CMTR2 knockout cells |
| Ribo-seq | Translation efficiency | Assess impact of cap2 methylation on protein synthesis |
| Mass spectrometry | Protein interactions and modifications | Identify CMTR2-associated factors |
| Fluorescence microscopy | Subcellular localization | Visualize tagged CMTR2 in cells |
| Cap-specific sequencing | Cap structure and methylation status | Detect cap2 marks on transcripts |
| CRISPR knockout screening | Gene essentiality and function | Test requirement for cap2 methyltransferases |
| Western blot | Protein expression levels | Validate knockout and overexpression models |
| qRT-PCR | RNA levels of target genes | Measure changes in cap2-modified transcripts |
RNA sequencing and cap analysis
RNA-seq and specialized cap-analysis methods can detect changes in cap-proximal methylation and transcript abundance upon perturbation of GO:0120550. Comparing wild-type and CMTR2 knockout cells reveals how loss of cap2 methylation affects RNA levels and processing.
Ribosome profiling
Ribo-seq measures translation efficiency and can reveal whether cap2 methylation influences protein synthesis. Combining Ribo-seq with RNA-seq in CMTR2 mutants helps distinguish effects on transcript stability from effects on translation.
Proteomics and interaction studies
Affinity purification and mass spectrometry can identify proteins that interact with CMTR2 and regulate its activity. Such studies help define the molecular context of GO:0120550 and its integration with RNA processing complexes.
Imaging and localization
Fluorescence microscopy of tagged CMTR2 can reveal its subcellular localization and dynamics. This approach helps determine where cap2 methylation occurs within the nucleus and cytoplasm.
How CRISPR Can Be Used to Study GO:0120550 methyltransferase cap2 activity
Knockout
CRISPR knockout of CMTR2 or CMTR1 can eliminate GO:0120550 activity and reveal its cellular consequences. Such models have demonstrated embryonic lethality and fertility defects in mice, establishing essential roles for cap2 methylation.
Point Mutation
Introducing point mutations in the catalytic domain of CMTR2 allows researchers to separate methyltransferase activity from other functions. These models help define the precise residues required for cap2 methylation and substrate recognition.
Knock-in
Knock-in of epitope or fluorescent tags into the endogenous CMTR2 locus enables tracking of the enzyme and its interactions. Tagged knock-in models facilitate localization and proteomic studies of cap2 methyltransferase.
Overexpression
Overexpression of CMTR2 or its partners can test whether increased cap2 methylation alters RNA fate and gene expression. Such models are useful for gain-of-function studies and for identifying downstream effects of the modification.
How EDITGENE Supports methyltransferase cap2 activity Research
Researchers studying methyltransferase cap2 activity-related genes often need to determine whether a candidate gene is causally involved in RNA modification, development, or disease. EDITGENE provides CRISPR-based cell models and screening services to interrogate GO:0120550 and its associated genes with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for methyltransferase cap2 activity research.
Frequently Asked Questions About methyltransferase cap2 activity
What is methyltransferase cap2 activity?
It is the enzyme activity that adds a 2'-O-methyl group to the ribose of the second transcribed nucleotide in mRNA and snRNA, as defined by GO:0120550.
What genes are involved in methyltransferase cap2 activity?
The principal human gene is CMTR2, with CMTR1 providing the upstream cap1 substrate required for the reaction.
What is the GO ID for methyltransferase cap2 activity?
The GO ID is GO:0120550.
Which enzyme catalyzes cap2 methylation?
CMTR2 is the main enzyme responsible for cap2 methylation in humans.
Why is cap2 methylation important for development?
Knockout studies show that loss of cap2 methylation causes embryonic lethality and fertility defects in mice.
What is the difference between cap1 and cap2 methylation?
Cap1 methylation modifies the first transcribed nucleotide, while cap2 methylation modifies the second; cap1 is a prerequisite for cap2.
What cofactor does cap2 methyltransferase use?
It uses S-adenosyl-L-methionine as the methyl donor and produces S-adenosyl-L-homocysteine.
How can I study cap2 methyltransferase activity in the lab?
CRISPR knockout, point-mutation, and knock-in models combined with RNA-seq and Ribo-seq are common approaches.
Is cap2 methylation conserved in evolution?
Yes, the 2'-O-ribose methyltransferase family responsible for cap2 methylation is conserved and has been described as horizontally mobile.
What diseases are linked to cap2 methylation defects?
Developmental failure and fertility defects have been observed in knockout models, and altered RNA methylation may affect immune sensing and cancer biology.
Conclusion
GO:0120550 methyltransferase cap2 activity is a conserved molecular function that modifies the 5' end of mRNA and snRNA, with essential roles in mammalian development and fertility. Its study provides insight into RNA cap biology, gene regulation, and disease mechanisms. CRISPR-based models and multi-omics methods are powerful tools for dissecting this activity and its downstream effects.
References
- 1. Dohnalkova M et al.. 2023. Essential roles of RNA cap-proximal ribose methylation in mammalian embryonic development and fertility.. Cell Rep 42(7):112786 PMID: 37436893
- 2. Yermalovich AV et al.. 2024. An essential role for Cmtr2 in mammalian embryonic development.. Dev Biol 516:47-58 PMID: 39094818
- 3. Werner M et al.. 2011. 2'-O-ribose methylation of cap2 in human: function and evolution in a horizontally mobile family.. Nucleic Acids Res 39(11):4756-68 PMID: 21310715
- 5. Sun J et al.. 2016. Pax6 associates with H3K4-specific histone methyltransferases Mll1, Mll2, and Set1a and regulates H3K4 methylation at promoters and enhancers.. Epigenetics Chromatin 9(1):37 PMID: 27617035
